Skip to main content

Advertisement

Log in

Topical calcipotriol vs narrowband ultraviolet B in treatment of alopecia areata: a randomized-controlled trial

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Alopecia areata is a chronic relapsing autoimmune inflammatory hair disorder with no novel therapy. The objectives of this study are to compare the efficacy of topical calcipotriol vs narrow band ultraviolet B phototherapy (NB-UVB) in the treatment of alopecia areata and its correlation with serum vitamin D3 levels. A randomized-controlled trial has been conducted on 60 patients with scalp alopecia areata randomized into four groups; topical calcipotriol, NB-UVB, both and placebo. All patients were evaluated by assessment of severity of alopecia areata by severity of alopecia tool (SALT) score at baseline and 3 months after treatment and vitamin D3 levels at baseline and after 3 months. SALT score and vitamin D3 levels were significantly improved in all groups except placebo after treatment with (P = 0.026, P = 0.005, P = 0.004, P = 0.140) and (P = 0.028, P = 0.011, P = 0.003, P = 0.725), respectively. Combined therapy showed non-significant improvement in SALT score (P = 0.530, P = 0.643), respectively, and significant improvement in serum vitamin D3 levels than each line alone with (P = 0.021, P = 0.044), respectively. Both topical calcipotriol and NB-UVB are effective therapies in the treatment of AA and associated with improvement of SALT score and vitamin D3 levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Noso S, Park C, Babaya N, Hiromine Y, Harada T, Ito H, Taketomo Y, Kanto K, Oiso N, Kawada A, Suzuki T, Kawabata Y, Ikegami H (2015) Organ specificity in autoimmune diseases: thyroid and islet autoimmunity in alopecia areata. J Clin Endocrinol Metab 100(5):1976–1983

    Article  CAS  PubMed  Google Scholar 

  2. Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP (2017) Alopecia areata. Nat Rev Dis Primers 16(3):17011

    Article  Google Scholar 

  3. Strazzulla LC, Wang EHC, Avila L (2018) Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol 78:1–12

    Article  PubMed  Google Scholar 

  4. Olsen EA (2011) Investigative guidelines for alopecia areata. Dermatol Ther 24:311–319

    Article  PubMed  Google Scholar 

  5. El Taieb MA, Ibrahim H, Nada EA, Seif Al-Din M (2017) Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: a trichoscopic evaluation. Dermatol Ther 30(1):e12437

    Article  Google Scholar 

  6. Amin SS, Sachdeva S (2013) Alopecia areata: an update. J Pak Assoc Dermatol 23(2):209–220

    Google Scholar 

  7. Amor K, Rashid R, Mirmirani P (2010) Does D matter? The role of vitamin D in hair disorders and hair follicle cycling. Dermatol Online J 16(2):3

    PubMed  Google Scholar 

  8. Yilmaz N, Serarslan G, Gokce C (2012) Vitamin D concentrations are decreased in patients with alopecia areata. Vitam Trace Elem 1:1–4

    Article  CAS  Google Scholar 

  9. Cerman A, Solak SS, Altunay IK (2014) Vitamin D deficiency in alopecia areata. Br J Dermatol 170(6):1299–1304

    Article  CAS  Google Scholar 

  10. Mahamid M, Abu-Elhija O, Samamra M, Mahamid A, Nseir W (2014) Association between vitamin D levels and alopecia areata. Isr Med Assoc J. 16(6):367–370

    PubMed  Google Scholar 

  11. Chen TC, Chimeh F, Lu Z, PersonKS ZhangA, KohnN Martinello S, Berkowitz R, Holick MF (2007) Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem 460:213–217

    Article  CAS  PubMed  Google Scholar 

  12. Nancy AL, Yehuda S (2009) Prediction and prevention of autoimmune skin disorders. Arch Dermatol Res 30:57–64

    Article  Google Scholar 

  13. Kim DH, Lee JW, Kim IS, Choi SY, Lim YY, Kim HM, Kim BJ, Kim MN (2012) Successful treatment of alopecia areata with topical calcipotriol. Ann Dermatol 24:341–344

    Article  PubMed  PubMed Central  Google Scholar 

  14. Çerman AA, Solak SS, Altunay İ, Küçükünal NA (2015) Topical calcipotriol therapy for mild-to-moderate alopecia areata: a retrospective study. J Drugs Dermatol 14(6):616–620

    PubMed  Google Scholar 

  15. Macdonald-Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG (2003) Guidelines for the management of alopecia areata. Br J Dermatol 149(4):692–699

    Article  CAS  PubMed  Google Scholar 

  16. Faul F, Erdfelder E, Lang AG, Buchner AG (2007) Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191

    Article  Google Scholar 

  17. El Taieb MA, Fayed HM, Aly SS, Ibrahim AK (2013) Assessment of serum 25-hydroxyvitamin D levels in children with atopic dermatitis: correlation with SCORAD index. Dermatitis 24:296–301

    Article  CAS  PubMed  Google Scholar 

  18. Bertolini M, Zilio F, Rossi A, Kleditzsch P, Emelianov VE, Gilhar A, Keren A, Meyer KC, Wang E, Funk W, McElwee K, Paus R (2014) Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata. PLoS One 9(5):94260

    Article  CAS  Google Scholar 

  19. Bouillon R, Carmeliet G, Verlinden L, Van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29:726–776

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Antico A, Tampoia M, Tozzoli R, Bizzaro N (2012) Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev 12:127–136

    Article  CAS  PubMed  Google Scholar 

  21. Alkhalifah A, Alsantali A, Wang E, McElwee K, Shapiro J (2010) Alopecia areata update (Part 1). Clinical picture, histopathology and pathogenesis. J Am Acad Dermatol 62:177–188

    Article  CAS  PubMed  Google Scholar 

  22. Segaert S, Simonart T (2008) The epidermal vitamin D system and innate immunity: some more light shed on this unique photoendocrine system dermatology. Dermatology 217(1):7–11

    Article  PubMed  Google Scholar 

  23. D’Ovidio R, Vessio M, D’Ovidio FD (2013) Reduced level of 25-hydroxyvitamin D in chronic/relapsing alopecia areata. Dermatoendocrinol 5:271–273

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Narang T, Daroach M, Kumaran MS (2017) Efficacy of topical calcipotriol in management of alopecia areata: a pilot study. Dermatol Ther 30(3):12464

    Article  Google Scholar 

  25. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M (2001) Extrarenal expression of 25-hydroxyvitamin D (3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86:888–894

    CAS  PubMed  Google Scholar 

  26. Reichrath J, Schilli M, Kerber A, Bahmer FA, Czarnetzki BM, Paus R (1999) Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol 131:477–482

    Article  Google Scholar 

  27. Xie Z, Komuves L, Yu QC, Elalieh H, Ng DC, Leary C, Chang S, Crumrine D, Bikle DD, Yoshizawa T, Kato S (2002) Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth. J Invest Dermatol 118:11–16

    Article  CAS  PubMed  Google Scholar 

  28. Parsad D, Bhatnagar A, De D (2012) Narrowband ultraviolet B for the treatment of vitiligo. Expert Rev Dermatol 5(4):445–459

    Article  Google Scholar 

  29. Kaur S, Mahajan BB, Mahajan R (2015) Comparative evaluation of intralesional triamcinolone acetonide injection, narrow band ultraviolet B, and their combination in alopecia areata. Int J Trichology 7(4):148–155

    Article  PubMed  PubMed Central  Google Scholar 

  30. Dilek B, Demirsoy EO, Aktürk AS, Kıran R (2011) Narrowband ultraviolet B phototherapy for alopecia areata. Photodermatol Photoimmunol Photomed 27:325–327

    Article  Google Scholar 

  31. Bogh MKB, Gullstrand J, Svensson A, Ljunggren B, Dorkhan M (2012) Narrowband UVB three times a week more effective in treating vitamin D deficiency than 1600 IU oral vitamin D3/day: a randomized clinical trial. Br J Dermatol 166(6):1365–2133

    Google Scholar 

  32. Lehmann B (2009) Role of vitamin D3 pathway in healthy and diseased skin-facts, contradictions, and hypotheses. Exp Dermatol 18(2):97–108

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Moustafa A. El Taieb.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

El Taieb, M.A., Hegazy, E.M., Ibrahim, H.M. et al. Topical calcipotriol vs narrowband ultraviolet B in treatment of alopecia areata: a randomized-controlled trial. Arch Dermatol Res 311, 629–636 (2019). https://doi.org/10.1007/s00403-019-01943-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-019-01943-8

Keywords

Navigation